Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.8%

31 terminated/withdrawn out of 209 trials

Success Rate

77.2%

-9.3% vs industry average

Late-Stage Pipeline

23%

49 trials in Phase 3/4

Results Transparency

19%

20 of 105 completed trials have results

Key Signals

36 recruiting20 with results24 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

105(60.0%)

Phase 4

27(15.4%)

Phase 3

22(12.6%)

Phase 2

14(8.0%)

Phase 1

6(3.4%)

Early Phase 1

1(0.6%)

175Total

N/A(105)

Phase 4(27)

Phase 3(22)

Phase 2(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (209)

Showing 20 of 209 trials

NCT07230886Not ApplicableRecruiting

Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

Role: collaborator

NCT02808260Recruiting

Predicting Development of SCAF in Device Patients

Role: lead

NCT03593759Phase 3Recruiting

Cardiac Sarcoidosis Randomized Trial

Role: lead

NCT06281977Phase 3Recruiting

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Role: lead

NCT04915261Phase 4Recruiting

A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery

Role: lead

NCT06183437Phase 4Recruiting

The STOP-MED CTRCD Trial

Role: collaborator

NCT07585175Recruiting

Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood

Role: lead

NCT05157932Not ApplicableActive Not Recruiting

An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation

Role: lead

NCT05434117Not ApplicableActive Not Recruiting

Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease

Role: lead

NCT07368062Recruiting

Mental Health After Dexmedetomidine for Electrical Storm

Role: lead

NCT05632601Not ApplicableActive Not Recruiting

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

Role: lead

NCT06907251Phase 3Not Yet Recruiting

Dapagliflozin for Long COVID Syndrome

Role: lead

NCT05136131Not ApplicableRecruiting

QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)

Role: lead

NCT07486986Not Yet Recruiting

Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

Role: lead

NCT00449852Not ApplicableCompleted

Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease

Role: lead

NCT00552591Not ApplicableCompleted

Family Heart Health Program: Randomized, Controlled Trial

Role: lead

NCT00265525Not ApplicableCompleted

Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease.

Role: lead

NCT05085860Not ApplicableCompleted

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation

Role: lead

NCT01477359Recruiting

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Role: lead

NCT00248352Not ApplicableCompleted

A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease

Role: lead